Network approaches to drug discovery

Expert Opinion on Drug Discovery

Volumn 8, Issue 1, 2013, Pages 7-20

  Chandra, Nagasuma ^a   Padiadpu, Jyothi ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Biological networks; Drug discovery; Genome scale modeling; Graph theory

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FLUOROURACIL; TACROLIMUS;

ADVERSE DRUG REACTION; BACTERIAL METABOLISM; BIOINFORMATICS; DNA METHYLATION; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG POTENTIATION; DRUG REPOSITIONING; DRUG SAFETY; DRUG TARGETING; DRUG TOXICITY; HUMAN; MOLECULAR INTERACTION; PATHOGENESIS; PERSONALIZED MEDICINE; PHARMACOGENETICS; POLYPHARMACY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; DRUG DISCOVERY; GENOMICS; HUMANS; INFORMATION SERVICES; MODELS, BIOLOGICAL; PROTEIN INTERACTION MAPS;

EID: 84871544734     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2013.741119     Document Type: Review

References (112)

1. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001;2:343-72
2. Chandra N. Computational systems approach for drug target discovery. Expert Opin Drug Discov 2009;4(12):1221-36
3. Wlodawer A, Vondrasek J. Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu Rev Biophys Biomol Struct 1998;27:249-84
4. Hellerstein MK. A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: advantages of pathway-based discovery. Metab Eng 2008;10(1):1-9
5. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12(1):56-68
6. Pawson T, Linding R. Network medicine. FEBS Lett 2008;582(8):1266-70
7. Kitano H. Systems biology: a brief overview. Science 2002;295(5560):1662- 4
8. Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med 2012 ;271(2):111-21
9. Chandra N. Computational approaches for drug target identification in pathogenic diseases. Expert Opin Drug Discov 2012;6(10):975-9
10. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5(2):101-13
11. Barabasi AL. Network medicine-from obesity to the "diseasome". N Engl J Med 2007;357(4):404-7
12. Loscalzo J, Barabasi AL. Systems biology and the future of medicine. Wiley Interdiscip Rev Syst Biol Med 2011;3(6):619-27
13. Bebek G, Koyuturk M, Price ND, Chance MR. Network biology methods integrating biological data for translational science. Brief Bioinform 2012;13(4):446-59
14. Erler JT, Linding R. Network medicine strikes a blow against breast cancer. Cell 2012;149(4):731-3
15. Mason O, Verwoerd M. Graph theory and networks in Biology. IET Syst Biol 2007;1(2):89-119
16. Pujol A, Mosca R, Farres J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 2010;31(3):115-23
17. Guez O, Gozolchiani A, Berezin Y, et al. Climate network structure evolves with North Atlantic Oscillation phases. EPL (Europhysics Letters) 2012;98(3):38006
18. Spiro Z, Kovacs IA, Csermely P. Drug-therapy networks and the prediction of novel drug targets. J Biol 2008;7(6):20
19. Yildirim MA, Goh KI, Cusick ME, et al. Drug-target network. Nat Biotechnol 2007;25(10):1119-26
20. Raman K, Chandra N. Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance. BMC Microbiol 2008;8:234
21. Raman K, Yeturu K, Chandra N. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2008;2:109
22. Cami A, Arnold A, Manzi S, Reis B. Predicting adverse drug events using pharmacological network models. Sci Transl Med 2011;3(114):114ra27
23. Campillos M, Kuhn M, Gavin AC, et al. Drug target identification using side-effect similarity. Science 2008;321(5886):263-6
24. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005;26(4):178-82
25. Schadt EE, Friend SH, Shaywitz DA. A network view of disease and compound screening. Nat Rev Drug Discov 2009;8(4):286-95
26. Zhao S, Iyengar R. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 2012;52:505-21
27. Chandra N, Kumar D, Rao K. Systems biology of tuberculosis. Tuberculosis 2011;91(5):487-96
28. Burge S, Kelly E, Lonsdale D, et al. Manual GO annotation of predictive protein signatures: the InterPro approach to GO curation. Database (Oxford) 2012;bar068
29. Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2010;39(Database issue):D561-8
30. Bader GD, Betel D, Hogue CWV. BIND: The biomolecular interaction network database. Nucleic Acids Res 2003;2003:31(1):248-50
31. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell 2011;144(6):986-98
32. Zhu X, Gerstein M, Snyder M. Getting connected: analysis and principles of biological networks. Genes Dev 2007;21(9):1010-24
33. Cabusora L, Sutton E, Fulmer A, Forst CV. Differential network expression during drug and stress response. Bioinformatics 2005;21(12):2898-905
34. Hu G, Agarwal P. Human disease-drug network based on genomic expression profiles. PLoS One 2009;4(8):e6536
35. Ideker T, Sharan R. Protein networks in disease. Genome Res 2008;18(4):644-52
36. Iyengar R, Zhao S, Chung SW, et al. Merging systems biology with pharmacodynamics. Sci Transl Med 2012;4(126):126ps7
37. Schadt EE, Bjorkegren JL. NEW: network-enabled wisdom in biology, medicine, and health care. Sci Transl Med 2012;4(115):115rv1
38. Yamanishi Y, Araki M, Gutteridge A, et al. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 2008;24(13):i232-40
39. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4(11):682-90
40. Paolini GV, Shapland RH, van Hoorn WP, et al. Global mapping of pharmacological space. Nat Biotechnol 2006;24(7):805-15
41. Magtanong L, Ho CH, Barker SL, et al. Dosage suppression genetic interaction networks enhance functional wiring diagrams of the cell. Nat Biotechnol 2011;29(6):505-11
42. Kanehisa M, Goto S, Furumichi M, et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2009;38(Database issue):D355-60
43. Croft D, O'Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2010;39(Database issue):D691-7
44. Mueller LA, Kugler KG, Netzer M, et al. A network-based approach to classify the three domains of life. Biol Direct 2011;6:53
45. Iorio F, Bosotti R, Scacheri E, et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 2010;107(33):14621-6
46. McKusick VA. Mendelian inheritance in man and its online version, OMIM. Am J Hum Genet 2007;80(4):588-604
47. Erler JT, Linding R. Network-based drugs and biomarkers. J Pathol 2009;220(2):290-6
48. Peer D, Hacohen N. Principles and strategies for developing network models in cancer. Cell 2011;144(6):864-73
49. Liu Y, Koyuturk M, Maxwell S, et al. Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data. AMIA Summits Transl Sci Proc 2012;2012:62-71
50. Kuhn M, Szklarczyk D, Franceschini A, et al. STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res 2012;40(Database issue):D876-80
51. Haupt VJ, Schroeder M. Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform 2011;12(4):312-26
52. Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature 2009;462(7270):175-81
53. Lee MJ, Ye AS, Gardino AK, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012;149(4):780-94
54. Chautard E, Thierry-Mieg N, Ricard-Blum S. Interaction networks: from protein functions to drug discovery. A review. Pathol Biol (Paris) 2009;57(4):324-33
55. Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol 2012;8:565
56. Boran AD, Iyengar R. Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel 2010;13(3):297-309
57. Zhong Q, Simonis N, Li QR, et al. Edgetic perturbation models of human inherited disorders. Mol Syst Biol 2009;5:321
58. Tan CS, Bodenmiller B, Pasculescu A, et al. Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Sci Signal 2009;2(81):ra39
59. Jornsten R, Abenius T, Kling T, et al. Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol 2011;7:486
60. Boshoff HI, Myers TG, Copp BR, et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 2004;279(38):40174-84
61. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophildriven blood transcriptional signature in human tuberculosis. Nature 2010;466(7309):973-7
62. Hopkins AL. Network pharmacology. Nat Biotechnol 2007;25(10):1110-11
63. Padiadpu J, Vashisht R, Chandra N. Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol 2011;4(4):311-22
64. Taylor IW, Linding R, Warde-Farley D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009;27(2):199-204
65. Raman K, Bhat AG, Chandra N. A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis. Mol Biosyst 2010;6(3):516-30
66. Goh KI, Cusick ME, Valle D, et al. The human disease network. Proc Natl Acad Sci USA 2007;104(21):8685-90
67. Liu H, Su J, Li J, et al. Prioritizing cancer-related genes with aberrant methylation based on a weighted protein-protein interaction network. BMC Syst Biol 2011;5:R53
68. Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010;11(5):R53
69. Lepeule J, Laden F, Dockery D, Schwartz J. Chronic exposure to fine particles and mortality: an extended follow-up of the harvard six cities study from 1974 to 2009. Environ Health Perspect 2012;120(7):965-70
70. Cheng TM, Gulati S, Agius R, et al. Understanding cancer mechanisms through network dynamics. Brief Funct Genomics 2012
71. Penrod NM, Cowper-Sal-lari R, Moore JH. Systems genetics for drug target discovery. Trends Pharmacol Sci 2011;32(10):623-30
72. Chavali AK, Blazier AS, Tlaxca JL, et al. Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease. BMC Syst Biol 2012;6:27
73. Raman K, Vashisht R, Chandra N. Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Mol Biosyst 2009;5(12):1740-51
74. Rahman SA, Schomburg D. Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks. Bioinformatics 2006;22(14):1767-74
75. Breitkreutz D, Hlatky L, Rietman E, Tuszynski JA. Molecular signaling network complexity is correlated with cancer patient survivability. Proc Natl Acad Sci USA 2012;109(23):9209-12
76. Agarwal S, Deane CM, Porter MA, Jones NS. Revisiting date and party hubs: novel approaches to role assignment in protein interaction networks. PLoS Comput Biol 2010;6(6):e1000817
77. Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011;2011;27(3):431-2
78. Hert J, Keiser MJ, Irwin JJ, et al. Quantifying the relationships among drug classes. J Chem Inf Model 2008;48(4):755-65
79. Huang PH, Mukasa A, Bonavia R, et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci USA 2007;104(31):12867-72
80. Schoeberl B, Pace EA, Fitzgerald JB, et al. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal 2009;2(77):ra31
81. Janes KA, Albeck JG, Gaudet S, et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005;310(5754):1646-53
82. Cokol M, Chua HN, Tasan M, et al. Systematic exploration of synergistic drug pairs. Mol Syst Biol 2011;7:544
83. Li S, Zhang B, Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol 2010;5(Suppl 1):S10
84. Janga SC, Tzakos A. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Mol Biosyst 2009;5(12):1536-48
85. Iskar M, Zeller G, Zhao XM, et al. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. Curr Opin Biotechnol 2011;
86. Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008;2008:36(Suppl 1):D901-D6
87. Maayan A, Jenkins SL, Goldfarb J, Iyengar R. Network analysis of FDA approved drugs and their targets. Mt Sinai J Med 2007;74(1):27-32
88. Kinnings SL, Jackson RM. Reversescreen3d: a structure-based ligand matching method to identify protein targets. J Chem Inf Model 2012;51(3):624-34
89. Mattison LK, Fourie J, Desmond RA, et al. Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians. Clin Cancer Res 2006;12(18):5491-5
90. Xie L, Li J, Bourne PE. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 2009;5(5):e1000387
91. Licata L, Briganti L, Peluso D, et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res 2012;40(Database issue):D857-61
92. von Eichborn J, Murgueitio MS, Dunkel M, et al. PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res 2010;39(Database issue):D1060-6
93. Kinnings SL, Liu N, Buchmeier N, et al. Drug discovery using chemical systems biology: repositioning the safe medicine comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol 2009;5(7):e1000423
94. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol 2011;162(6):1239-49
95. Feist AM, Herrgard MJ, Thiele I, et al. Reconstruction of biochemical networks in microorganisms. Nat Rev Microbiol 2009;7(2):129-43
96. Yang K, Ma W, Liang H, et al. Dynamic simulations on the arachidonic acid metabolic network. PLoS Comput Biol 2007;3(3):e55
97. Robinson CV, Sali A, Baumeister W. The molecular sociology of the cell. Nature 2007;450(7172):973-82
98. Xenarios I, Salwinski L, Duan XJ, et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002;30(1):303-5
99. Pagel P, Kovac S, Oesterheld M, et al. The MIPS mammalian protein-protein interaction database. Bioinformatics 2005;21(6):832-4
100. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human protein reference database-2009 update. Nucleic Acids Res 2009;37(Database issue):D767-72
101. Han K, Park B, Kim H, et al. HPID: The human protein interaction database. Bioinformatics 2004;20(15):2466-70
102. Kerrien S, Aranda B, Breuza L, et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res 2011;40(Database issue):D841-6
103. Johnson AD, O'Donnell CJ. An open access database of genome-wide association results. BMC Med Genet 2009;10:6
104. Scheer M, Grote A, Chang A, et al. BRENDA, the enzyme information system in 2011. Nucleic Acids Res 2011;39(Database issue):D670-6
105. Kuhn M, von Mering C, Campillos M, et al. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 2008;36(Database issue):D684-8
106. Irwin JJ, Sterling T, Mysinger MM, et al. ZINC: A Free Tool to Discover Chemistry for Biology. J Chem Inf Model 2012;52(7):1757-68
107. Chowdhary R, Tan SL, Zhang J, et al. Context-specific protein network miner-an online system for exploring context-specific protein interaction networks from the literature. PLoS One 2012;7(4):e34480
108. von Eichborn J, Bourne PE, Preissner R. Cobweb: a Java applet for network exploration and visualisation. Bioinformatics 2011;27(12):1725-6
109. Brown KR, Otasek D, Ali M, et al. NAViGaTOR: network analysis, visualization and graphing toronto. Bioinformatics 2009;25(24):3327-9
110. Garcia-Garcia J, Guney E, Aragues R, et al. Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinformatics 2010;11:56
111. Lee SA, Chan CH, Chen TC, et al. POINeT: protein interactome with sub-network analysis and hub prioritization. BMC Bioinformatics 2009;10:114
112. Assenov Y, Ramirez F, Schelhorn SE, et al. Computing topological parameters of biological networks. Bioinformatics 2008;24(2):282-4